ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005

NIH Defends NCI Sponsored Travel

December 3, 2010

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006